Allogeneic Hematopoietic Transplantation for Multiple Myeloma in the New Drugs Era: A Platform to Cure

by Alberto Mussetti, Maria Queralt Salas, Vittorio Montefusco
Published 2020-10-01

Is Post-Transplant Cyclophosphamide the New Methotrexate?

by Alberto Mussetti, Annalisa Paviglianiti, Rocio Parody, Anna Sureda
Published 2021-08-01

Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant Recipient

by Edoardo Melilli, Alberto Mussetti, Gabriela Sanz Linares, Marco Ruella, Charette La Salette, Alexandre Savchenko, Maria del Rosario Taco, Nuria Montero, Josep Grinyo, Alex Fava, Montse Gomà, Maria Meneghini, Anna Manonelles, Josepmaria Cruzado, Ana Sureda, Oriol Bestard
Published 2021-07-01

The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting

by Maria Condom, Alberto Mussetti, Clara Maluquer, Rocío Parody, Eva González‐Barca, Montserrat Arnan, Adaia Albasanz‐Puig, Helena Pomares, Maria Queralt Salas, Itziar Carro, Marta Peña, Victòria Clapes, Cristina Baca Cano, Ana Carla Oliveira Ramos, Gabriela Sanz‐Linares, Gabriel Moreno‐González, Santiago Mercadal, Concepcion Boqué, Carlota Gudiol, Eva Domingo‐Domènech, Anna Sureda
Published 2021-08-01

Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma

by Gloria Iacoboni, Guillermo Villacampa, Nuria Martinez‐Cibrian, Rebeca Bailén, Lucia Lopez Corral, Jose M. Sanchez, Manuel Guerreiro, Ana Carolina Caballero, Alberto Mussetti, Juan‐Manuel Sancho, Rafael Hernani, Pau Abrisqueta, Carlos Solano, Anna Sureda, Javier Briones, Alejandro Martin Garcia‐Sancho, Mi Kwon, Juan Luis Reguera‐Ortega, Pere Barba, GETH, GELTAMO Spanish Groups
Published 2021-05-01